15 results

S1 Transfusion support in hematopoietic stem cell transplantation
Dong Wook Jekarl, Jae Kwon Kim, Jay Ho Han, Howon Lee, Jaeeun Yoo, Jihyang Lim, Yonggoo Kim
KMSID: 1516082568   Blood Res. 2023;58(S1):S1-S7.   Published online 2023 February 27    DOI: http://dx.doi.org/10.5045/br.2023.2023004
      
S8 Transfusion thresholds: the need for a patient-centered approach in hematologic disorders that require chronic transfusion therapy
Han Joo Kim, Sang-Hyun Hwang, Heung-Bum Oh, Dae-Hyun Ko
KMSID: 1516082576   Blood Res. 2023;58(S1):S8-S10.   Published online 2023 February 27    DOI: http://dx.doi.org/10.5045/br.2023.2023009
      
S11 Practical issues in CAR T-cell therapy
Ja Min Byun
KMSID: 1516082566   Blood Res. 2023;58(S1):S11-S12.   Published online 2023 February 27    DOI: http://dx.doi.org/10.5045/br.2023.2023015
      
S13 Novel therapeutics for myelofibrosis
Sung-Eun Lee
KMSID: 1516082569   Blood Res. 2023;58(S1):S13-S19.   Published online 2023 March 9    DOI: http://dx.doi.org/10.5045/br.2023.2023012
      
S20 Management of adverse events in young adults and children with acute B-cell lymphoblastic leukemia receiving anti-CD19 chimeric antigen receptor (CAR) T-cell therapy
Jae Won Yoo
KMSID: 1516082570   Blood Res. 2023;58(S1):S20-S28.   Published online 2023 March 9    DOI: http://dx.doi.org/10.5045/br.2023.2023026
      
S29 Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
Eun-Ji Choi
KMSID: 1516082571   Blood Res. 2023;58(S1):S29-S36.   Published online 2023 March 9    DOI: http://dx.doi.org/10.5045/br.2023.2023017
      
S37 Prognostication in myeloproliferative neoplasms, including mutational abnormalities
Junshik Hong
KMSID: 1516082572   Blood Res. 2023;58(S1):S37-S45.   Published online 2023 March 16    DOI: http://dx.doi.org/10.5045/br.2023.2023038
      
S46 Current status of red blood cell manufacturing in 3D culture and bioreactors
Soonho Kweon, Suyeon Kim, Eun Jung Baek
KMSID: 1516082574   Blood Res. 2023;58(S1):S46-S51.   Published online 2023 April 7    DOI: http://dx.doi.org/10.5045/br.2023.2023008
      
S52 T-large granular lymphocytic leukemia
Sang Hyuk Park, Yoo Jin Lee, Youjin Kim, Hyun-Ki Kim, Ji-Hun Lim, Jae-Cheol Jo
KMSID: 1516082573   Blood Res. 2023;58(S1):S52-S57.   Published online 2023 April 7    DOI: http://dx.doi.org/10.5045/br.2023.2023037
      
S58 Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
Jae Joon Han
KMSID: 1516082575   Blood Res. 2023;58(S1):S58-S65.   Published online 2023 April 7    DOI: http://dx.doi.org/10.5045/br.2023.2023035
      
S66 Mycosis fungoides and Sézary syndrome
Hyewon Lee
KMSID: 1516082577   Blood Res. 2023;58(S1):S66-S82.   Published online 2023 April 30    DOI: http://dx.doi.org/10.5045/br.2023.2023023
      
S83 Novel therapeutic strategies for essential thrombocythemia/polycythemia vera
Seug Yun Yoon, Jong-Ho Won
KMSID: 1516082578   Blood Res. 2023;58(S1):S83-S89.   Published online 2023 April 30    DOI: http://dx.doi.org/10.5045/br.2023.2023013
      
S90 Plasmacytoid dendritic cell neoplasms
Yoo Jin Lee, Youjin Kim, Sang Hyuk Park, Jae-Cheol Jo
KMSID: 1516082579   Blood Res. 2023;58(S1):S90-S95.   Published online 2023 April 30    DOI: http://dx.doi.org/10.5045/br.2023.2023052
      
S96 Recent advances in diagnosis and therapy in systemic mastocytosis
Hyun Jung Lee
KMSID: 1516082580   Blood Res. 2023;58(S1):S96-S108.   Published online 2023 April 30    DOI: http://dx.doi.org/10.5045/br.2023.2023024
      
S109 Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation
Jieun Uhm
KMSID: 1516082567   Blood Res. 2023;58(S1):S109-S113.   Published online 2023 April 30    DOI: http://dx.doi.org/10.5045/br.2023.2023054
      
Articles from Blood Research are provided here courtesy of Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of